| Identification | Back Directory | [Name]
Bacoside A1 | [CAS]
58798-94-0 | [Synonyms]
Bacoside A1
Bacopaside l
α-L-Arabinopyranoside, (3β,16β,23R)-16,23:16,30-diepoxy-20-hydroxydammar-24-en-3-yl 3-O-α-L-arabinofuranosyl- | [Molecular Formula]
C40H64O12 | [MDL Number]
MFCD32201002 | [MOL File]
58798-94-0.mol | [Molecular Weight]
736.94 |
| Chemical Properties | Back Directory | [Boiling point ]
859.2±65.0 °C(Predicted) | [density ]
1.33±0.1 g/cm3 (20 ºC 760 Torr) | [pka]
12.82±0.70(Predicted) | [InChIKey]
ZQOWXUBGLKIVHR-JHGZBAGMNA-N |
| Hazard Information | Back Directory | [Definition]
The chemical compound with neuropharmacological properties and pseudo-jujubogenin moieties, known as aglycone units, is Bacoside A (dammarane-type triterpenoid saponin). This compound is composed of bacopaside III, bacopaside X, bacoside A3, and bacopasaponin C. Bacoside A1 is 3-O-(α-l-arabinofuranosyl[1→3])-α-l-arabinopyranoside, Bacoside A2 is 3-O-α-l-arabinopyranosyl-(1→5)-[α-l-arabinofuranosyl-(1→6)]-α-d-glucofuranoside, and Bacoside A3 is 3-O-α-l-arabinofuranosyl-(1→2)-[β-d-glucopyranosyl-(1→3)]-β-d-glucopyranoside. Bacoside A1 is a minor saponin from Bacopa monnieri[1-2]. | [References]
[1] Aimi Syamima Abdul Manap. “Bacopa monnieri, a Neuroprotective Lead in Alzheimer Disease: A Review on Its Properties, Mechanisms of Action, and Preclinical and Clinical Studies.” Drug Target Insights (2019).
[2] Saroya, A. and Jaswinder Singh. “Neuropharmacology of Bacopa monnieri with Reference to Bacosides.” (2018): 117–128.
|
|
| Company Name: |
Kono Chem Co.,Ltd
|
| Tel: |
029-86107037; 15829389671 |
| Website: |
http://www.konochemical.com |
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|